Rigshospitalet is the largest hospital in Denmark and the most highly specialised hospital in the country. The hospital's main building is a 16-storey functionalist highrise, one of the tallest structures in the central parts of the city.

There are 1,118 beds in Rigshospitalet, abdominalcentret, Medicinsk Gastroenterologisk klinik CA, 2121.

During the past decade, Rigshospitalet, abdominalcentret, Medicinsk Gastroenterologisk klinik CA, 2121 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rigshospitalet, abdominalcentret, Medicinsk Gastroenterologisk klinik CA, 2121" #1 collaborator was "TauroPharm" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rigshospitalet, abdominalcentret, Medicinsk Gastroenterologisk klinik CA, 2121" are "Catheter-Related Bloodstream Infection (CRBSI) Nos" (1 trials), "Catheter-related Bloodstream Infection (CRBSI) Nos" (1 trials) and "Intestinal Failure" (1 trials). Many other conditions were trialed in "Rigshospitalet, abdominalcentret, Medicinsk Gastroenterologisk klinik CA, 2121" in a lesser frequency.

Most popular intervention types in "Rigshospitalet, abdominalcentret, Medicinsk Gastroenterologisk klinik CA, 2121" are "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Heparin 100 IE/ml" (1 trials), "TaurolockTMHep100" (1 trials) and "catheter salvage" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rigshospitalet, abdominalcentret, Medicinsk Gastroenterologisk klinik CA, 2121" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rigshospitalet, abdominalcentret, Medicinsk Gastroenterologisk klinik CA, 2121". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rigshospitalet, abdominalcentret, Medicinsk Gastroenterologisk klinik CA, 2121, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rigshospitalet, abdominalcentret, Medicinsk Gastroenterologisk klinik CA, 2121, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".